The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: A Gynecologic Oncology Group Study

Life Domains ◽

Oncology Group ◽

The association between quality of life and overall survival in ovarian cancer patients during adjuvant chemotherapy: A Gynecologic Oncology Group study.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.5075 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 5075-5075

Author(s):

V. E. Von Gruenigen ◽

H. Q. Huang ◽

K. M. Gil ◽

H. E. Frasure ◽

D. K. Armstrong ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Overall Survival ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Gynecologic Oncology ◽

Oncology Group ◽

A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study

Journal of Pain and Symptom Management ◽

10.1016/j.jpainsymman.2009.09.022 ◽

2010 ◽

Vol 39 (5) ◽

pp. 839-846 ◽

Cited By ~ 25

Author(s):

Vivian E. von Gruenigen ◽

Helen Q. Huang ◽

Karen M. Gil ◽

Heidi E. Gibbons ◽

Bradley J. Monk ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Cancer Patients ◽

Gynecologic Oncology ◽

Life Domains ◽

Oncology Group ◽

Clinical Factors ◽

Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2018.05.017 ◽

2018 ◽

Vol 150 (1) ◽

pp. 119-126 ◽

Cited By ~ 3

Author(s):

Vivian E. von Gruenigen ◽

Helen Q. Huang ◽

David Cella ◽

MichaelA. Zevon ◽

Jason A. LaChance ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Gynecologic Oncology ◽

Oncology Group ◽

Care Needs ◽

Oncology Group Study ◽

Platinum Resistant

Effects of the WRITE Symptoms interventions on symptom and quality-of-life outcomes for women with recurrent ovarian cancer. GOG-259: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.03.073 ◽

2017 ◽

Vol 145 ◽

pp. 25-26

Author(s):

H.S. Donovan ◽

S. Sereika ◽

R.P. Edwards ◽

C.S. Bender ◽

B. Given ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Gynecologic Oncology ◽

Recurrent Ovarian Cancer ◽

Life Outcomes ◽

Oncology Group ◽

Oncology Group Study ◽

Quality Of Life Outcomes

Quality of life and survival in advanced cervical cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.01.047 ◽

2012 ◽

Vol 125 (2) ◽

pp. 315-319 ◽

Cited By ~ 22

Author(s):

Dana M. Chase ◽

Helen Q. Huang ◽

Lari Wenzel ◽

David Cella ◽

Richard McQuellon ◽

...

Keyword(s):

Quality Of Life ◽

Cervical Cancer ◽

Gynecologic Oncology ◽

Advanced Cervical Cancer ◽

Oncology Group ◽

Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.07.121 ◽

2017 ◽

Vol 147 (1) ◽

pp. 98-103 ◽

Cited By ~ 10

Author(s):

N.T. Phippen ◽

A.A. Secord ◽

S. Wolf ◽

G. Samsa ◽

B. Davidson ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Data Analysis ◽

Epithelial Ovarian Cancer ◽

Gynecologic Oncology ◽

Advanced Epithelial Ovarian Cancer

Oncology Group ◽

Ancillary Data ◽

Clinically meaningful quality-of-life changes in ovarian cancer: Results from gynecologic oncology group clinical trial 152

Clinical Therapeutics ◽

10.1016/s0149-2918(03)80262-x ◽

2003 ◽

Vol 25 ◽

pp. D26-D27

Author(s):

Lari Wenzel ◽

Bradley Monk ◽

Helen Huang ◽

David Cella ◽

Peter Rose

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Clinical Trial ◽

Gynecologic Oncology ◽

Life Changes ◽

Oncology Group

Quality of Life Outcomes From a Randomized Phase III Trial of Cisplatin With or Without Topotecan in Advanced Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70590-3 ◽

2006 ◽

Vol 2006 ◽

pp. 435-436

Author(s):

B.J. Monk

Keyword(s):

Quality Of Life ◽

Gynecologic Oncology ◽

Phase Iii ◽

Life Outcomes ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Advanced Carcinoma

Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2020.07.015 ◽

2020 ◽

Vol 159 (1) ◽

pp. 79-87

Author(s):

Krishnansu S. Tewari ◽

Michael W. Sill ◽

Robert L. Coleman ◽

Carol Aghajanian ◽

Robert Mannel ◽

...

Keyword(s):

Ovarian Cancer ◽

Overall Survival ◽

Phase Ii ◽

Gynecologic Oncology ◽

Recurrent Ovarian Cancer ◽

Oncology Group ◽

Oncology Group Study ◽

Randomized Phase Ii

A cost–utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: Incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2014.10.020 ◽

2015 ◽

Vol 136 (2) ◽

pp. 293-299 ◽

Cited By ~ 18

Author(s):

David E. Cohn ◽

Jason C. Barnett ◽

Lari Wenzel ◽

Bradley J. Monk ◽

Robert A. Burger ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Economic Model ◽

Gynecologic Oncology ◽

Cost Utility ◽

Cost Utility Analysis ◽

Oncology Group ◽

Utility Analysis